Form 4: Director Acquires Kronos Worldwide Stock

Dr. R. Gerald Turner, a Director at Kronos Worldwide Inc., acquired 5,550 shares of common stock through the company's Director Stock Plan.

Summary

• Dr. R. Gerald Turner, a Director of Kronos Worldwide Inc. (KRO), acquired 5,550 shares of common stock on May 13, 2026.
• The acquisition was made under the Kronos Worldwide, Inc. 2012 Director Stock Plan.
• These shares were issued for no cash consideration.
• Following this transaction, Dr. Turner beneficially owns 37,595.618 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine stock acquisition by a director under an existing plan, with no immediate indication of significant positive or negative company performance.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition was made through a stock plan, indicating a structured approach to director compensation and alignment with shareholders.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by directors, are common mechanisms for aligning executive interests with those of shareholders. This transaction within the chemical manufacturing sector, where Kronos Worldwide operates, is a routine disclosure under SEC regulations.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as it aligns director interests with shareholder value, though the impact is likely minimal given it's part of a stock plan.

Key Dates

Keywords

Kronos Worldwide, KRO, Form 4, Director Stock Plan, Beneficial Ownership, Common Stock, SEC Filing, Insider Trading